Treatment.com AI announces AI Pharmacy Assistant
31 July 2024 - 8:01AM
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939)
(“
Company” or “
Treatment”), a
healthcare tech company transforming patient care with AI-driven
clinical insights is excited to announce a new solution,
AI
Pharmacy Assistant designed to support pharmacists.
Pharmacists are playing an increasing role in the provision of
clinical decision support services, given the increasing number of
people without a GP and/or the time taken to book appointments.
As one example, the Ontario government recently announced
pharmacies provided over 1 million assessments for common ailments
since last year Ontario Exploring More Ways to Expand Role of
Pharmacists | Ontario Newsroom. This is representative of similar
trends being seen across Canada, UK and emerging legislation in the
US, all of which will lead to extending the role for pharmacists
within the healthcare continuum of care. Globally, pharmacists will
play a significant role in alleviating the shortages of healthcare
professionals, timeliness of patient support and mitigating the
financial pressures prevalent in today’s healthcare systems.
For many people, especially in underserved communities, the
pharmacist is often the only healthcare professional people see.
Therefore, providing these pharmacists with the tools and
confidence to administer a wider range of services, has a positive
impact for them and the wellbeing of their communities.
Working with pharmacists, Treatment is excited to be announcing
its new AI Pharmacy Assistant solution for
pharmacists, expected to launch later in 2024. The solution is
underpinned by Treatment’s AI powered proprietary Global Library of
Medicine (GLM), the most comprehensive and integrated online
medical library. The GLM has been created with hundreds of
credentialled clinicians globally to ensure the highest qualified
clinical information and support to all healthcare
professionals.
AI Pharmacy Assistant will be either accessible on a patient's
mobile device or through a kiosk tablet at the pharmacy. It will
support pharmacists in multiple ways:
- Reducing the time to take patient histories and symptoms using
Treatment’s GLM
- Automatically document all interactions with patients providing
an audit trail
- Extending confidence and support in expanded diagnostic support
provided to patients
- Minimize the risk of errors and increase clinical
efficiency
- Providing comprehensive diagnostic
and symptom information backed by the most reliable and up-to-date
medical research
The global clinical decision support systems (CDSS) market is
projected to grow significantly, reaching approximately $4.05
billion by 2029 from $2.46 billion in 2024, driven by technological
advancements and the integration of AI and machine learning in
healthcare decision-making processes. Whilst there is a clear
desire to expand the pharmacist's scope of practice, there is also
a huge shortage of pharmacists globally. Therefore, pharmacists are
being stretched at both ends: more work, less staff. Supportive and
accurate support tools which can be trusted, such as Treatment’s AI
Pharmacy Assistant, will be a pivotal part of the solution.
Dr. Essam Hamza, CEO of Treatment.com AI, comments: “We are
excited to announce another new product line and revenue stream for
our GLM platform. We have been working closely with industry
professionals and government agencies to ensure we create a
valuable tool that will have the most immediate impact for all the
stakeholders. For Payers, we help improve efficiency and hopefully
avoid patient complications and unneeded costly hospital visits.
For the Pharmacists, we help relieve administrative headaches and
give them comfort to see more patients. Finally, and most
importantly, for the Patient, we provide more and better access to
care for themselves and their family members.”
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI to positively disrupt
the healthcare sector and impact current inefficiencies and
challenges. Over the past 7+ years and with the input of hundreds
of healthcare professionals globally, Treatment.com AI has built
the world’s most intelligent, personalized healthcare AI engine,
the Global Library of Medicine (GLM). Providing the highest
qualified clinical information and support to all healthcare
professionals, the GLM delivers >92%+ accuracy on first
diagnosis as well as providing recommended tests (physical and
lab), x-rays, and billing codes. The platform’s quality and
transparency are unrivaled, as the GLM provides an explanation of
every step and likelihood associated with every symptom.
Treatment.com AI also focuses on the next generation of healthcare
professionals supporting Medical and Nursing schools, who utilize
the GLM to help enhance the future clinical skills of their
students. Treatment.com AI is focused on using AI for good and
utilizing its GLM platform to bring the possibility of health
equity and inclusion for disenfranchised communities.
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
ehamza@treatment.com
If you would like to find out more about Treatment’s products
and services, please email at info@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888)
788-8955
Cautionary Statements
This news release contains forward-looking statements that are
based on Treatment.com AI’s expectations, estimates and projections
regarding its business and the economic environment in which it
operates, including with respect to the implementation of its
shareholder communications initiative and the timing thereof.
Although Treatment.com believes the expectations expressed in such
forward-looking statements are based on reasonable assumptions,
such statements are not guarantees of future performance and
involve risks and uncertainties that are difficult to control or
predict. Therefore, actual outcomes and results may differ
materially from those expressed in these forward-looking
statements, and readers should not place undue reliance on such
statements. These forward-looking statements speak only as of the
date on which they are made, and Treatment.com undertakes no
obligation to update them publicly to reflect new information or
the occurrence of future events or circumstances unless otherwise
required to do so by law.
The Canadian Securities Exchange does not accept responsibility
for the adequacy or accuracy of this release.